240 related articles for article (PubMed ID: 30706368)
1. Aluminum in Neurological and Neurodegenerative Disease.
McLachlan DRC; Bergeron C; Alexandrov PN; Walsh WJ; Pogue AI; Percy ME; Kruck TPA; Fang Z; Sharfman NM; Jaber V; Zhao Y; Li W; Lukiw WJ
Mol Neurobiol; 2019 Feb; 56(2):1531-1538. PubMed ID: 30706368
[TBL] [Abstract][Full Text] [Related]
2. Aluminum in neurological disease - a 36 year multicenter study.
Lukiw WJ; Kruck TPA; Percy ME; Pogue AI; Alexandrov PN; Walsh WJ; Sharfman NM; Jaber VR; Zhao Y; Li W; Bergeron C; Culicchia F; Fang Z; McLachlan DRC
J Alzheimers Dis Parkinsonism; 2019; 8(6):. PubMed ID: 31179161
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.
Islam MT
Neurol Res; 2017 Jan; 39(1):73-82. PubMed ID: 27809706
[TBL] [Abstract][Full Text] [Related]
4. Aluminium in human brain tissue from donors without neurodegenerative disease: A comparison with Alzheimer's disease, multiple sclerosis and autism.
Exley C; Clarkson E
Sci Rep; 2020 May; 10(1):7770. PubMed ID: 32385326
[TBL] [Abstract][Full Text] [Related]
5. microRNA-146a-5p, Neurotropic Viral Infection and Prion Disease (PrD).
Pogue AI; Lukiw WJ
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502105
[TBL] [Abstract][Full Text] [Related]
6. Prion protein immunohistochemical staining in the brains of monkeys with transmissible spongiform encephalopathy.
Baker HF; Ridley RM; Wells GA; Ironside JW
Neuropathol Appl Neurobiol; 1998 Dec; 24(6):476-86. PubMed ID: 9888158
[TBL] [Abstract][Full Text] [Related]
7. A reexamination of aluminum in Alzheimer's disease: analysis by energy dispersive X-ray microprobe and flameless atomic absorption spectrophotometry.
Jacobs RW; Duong T; Jones RE; Trapp GA; Scheibel AB
Can J Neurol Sci; 1989 Nov; 16(4 Suppl):498-503. PubMed ID: 2804812
[TBL] [Abstract][Full Text] [Related]
8. P53- and CD95-associated apoptosis in neurodegenerative diseases.
de la Monte SM; Sohn YK; Ganju N; Wands JR
Lab Invest; 1998 Apr; 78(4):401-11. PubMed ID: 9564885
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in Our Molecular and Mechanistic Understanding of Misfolded Cellular Proteins in Alzheimer's Disease (AD) and Prion Disease (PrD).
Lukiw WJ
Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204666
[TBL] [Abstract][Full Text] [Related]
10. Functional Genomics meets neurodegenerative disorders. Part II: application and data integration.
Hoerndli F; David DC; Götz J
Prog Neurobiol; 2005 Jun; 76(3):169-88. PubMed ID: 16169146
[TBL] [Abstract][Full Text] [Related]
11. Brain destruction alone does not elevate brain aluminum.
Traub RD; Rains TC; Garruto RM; Gajdusek DC; Gibbs CJ
Neurology; 1981 Aug; 31(8):986-90. PubMed ID: 6455608
[TBL] [Abstract][Full Text] [Related]
12. Expression of immunohistochemical markers on microglia in Creutzfeldt-Jakob disease and Alzheimer's disease: morphometric study and review of the literature.
Wojtera M; Sobów T; Kłoszewska I; Liberski PP; Brown DR; Sikorska B
Folia Neuropathol; 2012; 50(1):74-84. PubMed ID: 22505366
[TBL] [Abstract][Full Text] [Related]
13. Interplay of Ferritin Accumulation and Ferroportin Loss in Ageing Brain: Implication for Protein Aggregation in Down Syndrome Dementia, Alzheimer's, and Parkinson's Diseases.
Raha AA; Biswas A; Henderson J; Chakraborty S; Holland A; Friedland RP; Mukaetova-Ladinska E; Zaman S; Raha-Chowdhury R
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162984
[TBL] [Abstract][Full Text] [Related]
14. Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies.
Catalá-López F; Suárez-Pinilla M; Suárez-Pinilla P; Valderas JM; Gómez-Beneyto M; Martinez S; Balanzá-Martínez V; Climent J; Valencia A; McGrath J; Crespo-Facorro B; Sanchez-Moreno J; Vieta E; Tabarés-Seisdedos R
Psychother Psychosom; 2014; 83(2):89-105. PubMed ID: 24458030
[TBL] [Abstract][Full Text] [Related]
15. [The other dementias: the neuropathology of the non-Alzheimer's disease dementias].
Hamilton RL
Rev Neurol; 2003 Jul 16-31; 37(2):130-9. PubMed ID: 12938072
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
17. Mathematical models for the diffusion magnetic resonance signal abnormality in patients with prion diseases.
Figini M; Alexander DC; Redaelli V; Fasano F; Grisoli M; Baselli G; Gambetti P; Tagliavini F; Bizzi A
Neuroimage Clin; 2015; 7():142-54. PubMed ID: 25610776
[TBL] [Abstract][Full Text] [Related]
18. Amyloid precursor protein gene isoforms in Alzheimer's disease and other neurodegenerative disorders.
Panegyres PK; Zafiris-Toufexis K; Kakulas BA
J Neurol Sci; 2000 Feb; 173(2):81-92. PubMed ID: 10675649
[TBL] [Abstract][Full Text] [Related]
19. Comparative quantitative study of 'signature' pathological lesions in the hippocampus and adjacent gyri of 12 neurodegenerative disorders.
Armstrong RA; Cairns NJ
J Neural Transm (Vienna); 2015 Oct; 122(10):1355-67. PubMed ID: 25929331
[TBL] [Abstract][Full Text] [Related]
20. [Creutzfeldt-Jakob disease--a human prion disease].
Buchwald E; Vorstrup S
Nord Med; 1996 Jun; 111(6):180-3. PubMed ID: 8700643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
